Search research articles
Contact Us
Filters
Showing results (1-10 of 198) with videos related to
Page
of 20
Sort By:
JACC. Cardiovascular Interventions
|
February 19, 2018
To EncourAGE Individualized Dual Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation: A New pAGE of an Intriguing Book
Giuseppe Gargiulo
Giornale Italiano Di Cardiologia (2006)
|
July 8, 2016
[Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation]
Giuseppe Gargiulo, Marco Valgimigli
Journal of Thrombosis and Thrombolysis
|
August 18, 2021
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment
Mattia Galli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
August 1, 2021
Aspirin Monotherapy After BioFreedom Stent and 1-Month DAPT: Is Less More Even in Low-Risk Patients?
Giuseppe Gargiulo, Giovanni Esposito
JAMA Cardiology
|
March 16, 2017
Deciding on the Duration of Dual Antiplatelet Therapy-When the Choice Between 2 Evils Is Still Evil
Marco Valgimigli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
June 20, 2016
Bivalirudin in Current Practice: Melius Abundare Quam Deficere?
Marco Valgimigli, Giuseppe Gargiulo
Revista Espanola De Cardiologia (English Ed.)
|
June 29, 2016
Bivalirudin Versus Unfractionated Heparin for Acute Coronary Syndromes: Do We Have a Winner?
Giuseppe Gargiulo, Marco Valgimigli
Journal of Thoracic Disease
|
December 23, 2017
Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle
Giuseppe Gargiulo, Marco Valgimigli
JACC. Cardiovascular Interventions
|
May 21, 2018
Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention: Is Access Site the New Piece of the Puzzle?
Marco Valgimigli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
June 24, 2017
DAPT Duration After Drug-Eluting Stent Implantation: No News Is Good News
Marco Valgimigli, Giuseppe Gargiulo
Page
of 20
Search research articles
Search
Showing results (1-10 of 198) with videos related to
Sort By:
Page
of 20
JACC. Cardiovascular Interventions
|
February 19, 2018
To EncourAGE Individualized Dual Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation: A New pAGE of an Intriguing Book
Giuseppe Gargiulo
Giornale Italiano Di Cardiologia (2006)
|
July 8, 2016
[Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation]
Giuseppe Gargiulo, Marco Valgimigli
Journal of Thrombosis and Thrombolysis
|
August 18, 2021
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment
Mattia Galli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
August 1, 2021
Aspirin Monotherapy After BioFreedom Stent and 1-Month DAPT: Is Less More Even in Low-Risk Patients?
Giuseppe Gargiulo, Giovanni Esposito
JAMA Cardiology
|
March 16, 2017
Deciding on the Duration of Dual Antiplatelet Therapy-When the Choice Between 2 Evils Is Still Evil
Marco Valgimigli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
June 20, 2016
Bivalirudin in Current Practice: Melius Abundare Quam Deficere?
Marco Valgimigli, Giuseppe Gargiulo
Revista Espanola De Cardiologia (English Ed.)
|
June 29, 2016
Bivalirudin Versus Unfractionated Heparin for Acute Coronary Syndromes: Do We Have a Winner?
Giuseppe Gargiulo, Marco Valgimigli
Journal of Thoracic Disease
|
December 23, 2017
Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle
Giuseppe Gargiulo, Marco Valgimigli
JACC. Cardiovascular Interventions
|
May 21, 2018
Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention: Is Access Site the New Piece of the Puzzle?
Marco Valgimigli, Giuseppe Gargiulo
JACC. Cardiovascular Interventions
|
June 24, 2017
DAPT Duration After Drug-Eluting Stent Implantation: No News Is Good News
Marco Valgimigli, Giuseppe Gargiulo
Page
of 20